Document is current
Any future updates will be listed below
-
Authors
Sasakawa, Yuji
Tatematsu, Yoshitaka
Kato, Joichiro
Fujii, Maya
Okamoto, Naoki
Inaguma, Daijo https://orcid.org/0000-0002-3977-5933
-
Funding
Funding for this research was provided by:
Aichi Kidney Foundation
- License Information
-
More Information
Article History
Received: 1 March 2023
Accepted: 24 May 2023
First Online: 2 June 2023
Declarations
:
: Honoraria (lecture fee): D. Inaguma received lecture fee from Kyowa Kirin Co., Ltd., Kissei Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd. Sanwa Kagaku kenkyusho Co., Ltd. Grants received: D. Inaguma received research funding from Sanwa Kagaku Kenkyusho Co., Ltd.
: The AICOPP was conducted following Ethical guidelines for Clinical Research by the Japanese Ministry of Health, Labor, and Welfare (created July 30, 2003; full revision December 28, 2004; full revision July 31, 2008) and the Helsinki Declaration (revised 2013) and was approved by the clinical research ethics committees at each AICOPP group facility (Approval Number: 20110823-3).
: The subjects were given oral and written explanations of the aim of the study and provided consent in writing. Trial registration is UMIN 7096. Registered 18 January 2012.
